RDSMY Stock UPDATES Royal D S M Nv ADR (RDSMY) 16.8050 08/28/2014

New Post Public Reply Private Reply Replies (0) Message Board

Aug 28, 2014 at 5:39 PM

Royal D S M Nv ADR (RDSMY) 16.8050 $RDSMY

Stock to Avoid: Axiall Corporation - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jul 07, 2:30PM CDT
Zacks Investment Research downgraded Axiall Corporation (AXLL) to a Zacks Rank #5 (Strong Sell) on Jul 5, 2014.

PPG Industries Closes Homax Group Acquisition - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 03, 12:10PM CDT
PPG Industries' (PPG) has completed the acquisition of Homax Group for an undisclosed price.

PPG Industries Closes Acquisition of Masterwork - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 02, 4:35PM CDT
Coatings giant, PPG Industries Inc.'s (PPG) North American architectural coatings business has completed the acquisition of Masterwork Paint Company.

Praxair Hikes Gas prices to Cover Increased Costs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 02, 12:40PM CDT
Praxair Inc. (PX), an industrial gas producer and supplier, announced price hikes for industrial, specialty and medical gases for its customers in the U.S., Canada, and Puerto Rico.

FMC Corp. Snips View as Cold Winter Hits Agriculture Biz - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jun 24, 12:45PM CDT
FMC Corp. (FMC) has cut its earnings forecasts for second-quarter and full-year 2014 on weakness in its agriculture business.

Celanese Launches Vinamul Elite Emulsions - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jun 23, 12:15PM CDT
Chemical maker Celanese (CE) has launched a new range of next-generation VAE emulsions.

Praxair Starts Oxygen Supply Plant in Uruguay - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jun 19, 5:25PM CDT
Praxair Inc. (PX) yesterday started a new plant for supplying oxygen at the Montes del Plata pulp mill located in Punta Pereira, Uruguay. The plant can produce 125 tons of gaseous oxygen per day through non-cryogenic vacuum-pressure-swing-adsorption (VPSA) technology.

Dow Chemical Launching Surface Finishing Solutions - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jun 19, 12:00PM CDT
The Dow Chemical Company's (DOW) business unit ??? Dow Electronic Materials ??? will introduce more sustainable surface finishing solutions for the electronic and industrial finishing markets.

Air Products Surges after Naming Rockwood's Ghasemi as CEO - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jun 19, 11:50AM CDT
Shares of Air Products and Chemicals Inc. (APD) jumped after its board named Seifi Ghasemi its new chairman, president and chief executive officer (CEO), effective July 1.

PPG Industries Spends $40M on Brazil Plant Expansion - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 18, 12:50PM CDT
PPG Industries (PPG) is investing roughly $40 million to expand its coatings manufacturing facility in Brazil.

Koppers Holdings Lowered to Strong Sell - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jun 17, 12:50PM CDT
Zacks Investment Research downgraded Koppers Holdings Inc. (KOP) to a Zacks Rank #5 (Strong Sell) on Jun 17, 2014. Going by the Zacks model, companies holding a Zacks Rank #5 have strong chances of performing worse than the broader market.

Eastman Chemical Restores Operations at Kingsport Plant - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jun 16, 9:20AM CDT
Chemical maker Eastman Chemical Company (EMN) announced that it has resumed operations at its site in Kingsport, TN, following an unplanned shutdown on Jun 4.

PPG Industries Completes Acquisition of Canal Supplies - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 13, 2:30PM CDT
PPG Industries Inc. (PPG) announced that it has completed the acquisition of Canal Supplies Inc.

Dow Chemical and Ampac Join Forces for PacXpert Packaging Technology - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jun 12, 5:00PM CDT
The Dow Chemical Company (DOW) announced that it has won the flexible packaging converter, Ampac, as the first licensee of its PacXpert packaging technology in North America.

Air Products and MATHESON Commence Helium Production in Wyoming - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jun 12, 3:57PM CDT
Chemical giant Air Products & Chemicals Inc. (APD) and Matheson Tri-Gas, Inc. (MATHESON) announced the commencement of production operations at their jointly-owned liquid helium production plant near Big Piney, WY.

Cimarex Reports Fourth-Quarter and Full-Year 2013 Results (unaudited)
PR Newswire - Wed Feb 19, 7:00AM CST
Cimarex Energy Co. (NYSE: XEC) today reported adjusted fourth-quarter 2013 net income of $117.6 million, or $1.35 per diluted share, compared to fourth-quarter 2012 adjusted net income of $102.8 million, or $1.19 per diluted share(1). For the year, adjusted net income totaled $469.3 million, or $5.38 per diluted share, as compared to 2012 adjusted net income of $366.8 million, or $4.22 per diluted share. See attached table to the financial statements for a full reconciliation of adjusted net income.

OTC Markets Group Reports 2013 Trading Statistics and Highlights
PR Newswire - Wed Jan 29, 9:17AM CST
OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial marketplaces, today announced its trading statistics and highlights for 2013 as well as its plans for 2014.

DSM Begins Trading on OTCQX®
PR Newswire - Tue Aug 06, 6:00AM CDT
OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial marketplaces, today announced that DSM (OTCQX: RDSMY; NYSE Euronext: DSM), a global science-based company active in health, nutrition and materials, has chosen to have its American Depositary Receipts (ADRs) traded on OTCQX®, the best marketplace with qualified companies.

DSM and DecImmune Therapeutics Sign Agreement to Develop N2 Pathway Blocking Antibody
PR Newswire - Mon Apr 22, 1:00AM CDT
DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM (NYSE, Euronext: DSM KON), announced today that it has signed an agreement with venture capital funded DecImmune Therapeutics of Cambridge, Massachusetts, USA

DSM announces June opening of new cGMP biopharmaceutical manufacturing operation in Brisbane, Australia
PR Newswire - Mon Apr 22, 1:00AM CDT
The DSM facility was built with cooperation from the Queensland and Commonwealth Governments of Australia. Karen King, President of DSM Biologics, the biopharmaceutical manufacturing business of DSM Pharmaceutical Products, stated, "We are thrilled to announce the June opening of our new cGMP facility in Brisbane. This operation combines DSM's twenty five years of experience and high quality track record in mammalian cell culture manufacturing with a state-of-the-art commercial and development facility. Our partnership with the Government of Queensland and the Commonwealth of Australia has led to this important addition to the Australian biotechnology industry and will be a key contributor to the entire Asia-Pacific region."

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

EZaccessMD Data Breach: Class Action Lawsuit Looms

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

PASCAL's Holiday Gift Edit: Timeless Watches Shine

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Novo's Research Unlocks New Insights into Food Noise

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

YSTUDIO's Pens: A Nod to the Power of Writing

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Fluence Energy Faces Leadership Departures Amid Legal Woes

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Servier's Data on Tovorafenib Shows Promise in pLGG

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

AppLovin Legal Woes: A Deep Dive into Investor Claims

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

WHO and RCSI Bahrain Join Forces on Health Initiatives

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...